13D Filing: James E. Flynn and Homology Medicines Inc (FIXX)

Page 13 of 20

Page 13 of 20 – SEC Filing

CUSIP No.  438083107 Page 13 of 18 Pages

Item 5. Interest in Securities of the Issuer.

(a)

(1)       Deerfield
Mgmt III

Number of shares: 2,613,517
(comprised of shares held by Deerfield Private Design Fund III)

Percentage of shares: 6.98%

(2)        Deerfield
Private Design Fund III

Number of shares: 2,613,517

Percentage of shares: 6.98%

(3)        Deerfield
Mgmt

Number of shares: 625,000 (comprised of shares held by
Deerfield Partners)

Percentage of shares: 1.67%

(4)       Deerfield
Partners

Number of shares: 625,000

Percentage of shares: 1.67%

(5)       Deerfield
Healthcare Innovations Fund

Number of shares: 1,988,518

Percentage of shares: 5.31%

(6)       Deerfield
Mgmt HIF

Number
of shares: 1,988,518 (comprised of shares held by Deerfield Healthcare Innovations Fund)

Percentage of shares: 5.31%

(7)       Deerfield
Management

Number of shares: 5,227,035
(comprised of shares held by Deerfield Private Design Fund III, Deerfield Partners and Deerfield Healthcare Innovations Fund)

Percentage of shares: 13.96%

(8)       Flynn

Number of shares: 5,227,035
(comprised of shares held by Deerfield Private Design Fund III, Deerfield Partners and Deerfield Healthcare Innovations Fund)

Percentage of shares: 13.96%

Follow Q32 Bio Inc. (NASDAQ:QTTB)

Page 13 of 20